Skip to content

Author

W. E. El Nekidy

1 paper indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Oct 2026

Assessing the clinical impact of carbapenem pre-authorisation on clinical outcomes in a setting with a high prevalence of extended-spectrum beta-lactamase producing organisms: a focus on the Middle East.

BACKGROUND Data on carbapenem pre-authorisation in hospitals with a high prevalence of extended-spectrum β-lactamase (ESBL) producing organisms is scarce. Therefore, the aim of this study was to evaluate the impact of implementing a carbapenem pre-authorisation policy on patients admitted to our acute care floors, focu...

Amna Nauman, W. E. El Nekidy, E. Abidi et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.